Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INOV
2426
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1M | ﹤0.01% |
60,222
-91,613
| -60% | -$1.74M |
|
2427
Protara Therapeutics
TARA
$223M
| $1M | ﹤0.01% |
+42,419
| New | +$1.24M |
|
2428
Allogene Therapeutics
ALLO
$635M
| $1M | ﹤0.01% |
51,501
-20,392
| -28% | -$486K |
|
|
TSC
2429
DELISTED
TriState Capital Holdings, Inc.
TSC
| $999K | ﹤0.01% |
103,357
+57,702
| +126% | +$1.16M |
|
|
AZUL
2430
DELISTED
Azul
AZUL
| $998K | ﹤0.01% |
97,910
+80,168
| +452% | +$2.54M |
|
2431
PUT
Best Buy
BBY
$18B
| $998K | ﹤0.01% |
17,500
-216,800
| -93% | -$17.2M |
|
2432
CALL
UnitedHealth
UNH
$370B
| $998K | ﹤0.01% |
4,000
-101,600
| -96% | -$28M |
|
2433
Adeia
ADEA
$3.07B
| $995K | ﹤0.01% |
270,455
+117,614
| +77% | +$501K |
|
|
AMWD
2434
DELISTED
American Woodmark
AMWD
| $995K | ﹤0.01% |
21,844
+15,287
| +233% | +$1.41M |
|
|
NREF
2435
NexPoint Real Estate Finance
NREF
$327M
| $992K | ﹤0.01% |
+102,764
| New | +$1.57M |
|
2436
Teradyne
TER
$63.1B
| $991K | ﹤0.01% |
18,289
-16,191
| -47% | -$1.03M |
|
2437
CALL
Universal Health Services
UHS
$10.2B
| $991K | ﹤0.01% |
10,000
| – | – |
|
2438
Precision BioSciences
DTIL
$182M
| $989K | ﹤0.01% |
+5,466
| New | +$1.43M |
|
|
B
2439
Barrick Mining
B
$64B
| $989K | ﹤0.01% |
53,989
-3,926,653
| -99% | -$73.6M |
|
2440
Murphy Oil
MUR
$5.5B
| $988K | ﹤0.01% |
161,153
+22,837
| +17% | +$420K |
|
2441
CALL
TG Therapeutics
TGTX
$7.07B
| $984K | ﹤0.01% |
100,000
-350,000
| -78% | -$4.42M |
|
2442
Kirby Corp
KEX
$6.98B
| $982K | ﹤0.01% |
22,586
-90,795
| -80% | -$6.18M |
|
2443
PUT
C.H. Robinson
CHRW
$17.2B
| $980K | ﹤0.01% |
14,800
+12,100
| +448% | +$869K |
|
2444
CEMIG Preferred Shares
CIG
$6.24B
| $977K | ﹤0.01% |
1,127,912
-4,729,670
| -81% | -$7.29M |
|
|
INN
2445
Summit Hotel Properties
INN
$749M
| $976K | ﹤0.01% |
231,305
+200,473
| +650% | +$1.89M |
|
2446
Benchmark Electronics
BHE
$2.91B
| $974K | ﹤0.01% |
48,714
-35,745
| -42% | -$1.01M |
|
|
SUP
2447
DELISTED
Superior Industries International
SUP
| $974K | ﹤0.01% |
811,534
-7,175
| -0.9% | -$18.9K |
|
2448
Coeur Mining
CDE
$16.7B
| $973K | ﹤0.01% |
303,142
-335,081
| -53% | -$1.74M |
|
|
DMTK
2449
DELISTED
DermTech, Inc. Common Stock
DMTK
| $971K | ﹤0.01% |
86,274
+75,593
| +708% | +$928K |
|
|
NBIS
2450
Nebius Group N.V.
NBIS
$57.3B
| $970K | ﹤0.01% |
28,484
-548,605
| -95% | -$22.6M |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.